ATC Group: C04A Peripheral vasodilators

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C04A in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C04 Peripheral vasodilators
3 C04A Peripheral vasodilators

Group C04A contents

Code Title
C04AA 2-amino-1-phenylethanol derivatives
C04AB Imidazoline derivatives
C04AC Nicotinic acid and derivatives
C04AD Purine derivatives
C04AE Ergot alkaloids
C04AF Enzymes
C04AX Other peripheral vasodilators

Active ingredients in C04A

Active Ingredient

Naftidrofuryl oxalate is a powerful vasodilator agent with an antagonist effect on 5-HT2 receptors of the smooth muscle cells. The vasodilator effect, which occurs in both the cerebral and peripheral circulation, is probably the main action. It is claimed that this action protects cells against the metabolic effects of ischaemia.

Pentoxifylline has been shown to increase leukocyte deformability and to inhibit neutrophil adhesion and activation.

Phenoxybenzamine is a non competitive long acting α-adrenergic receptor antagonist.

Phentolamine is a competitive non-selective α1- and α2-adrenergic receptor blocker of relatively short duration of action. It causes vasodilatation and a fall in blood pressure resulting from the blockade of both post-junctional vascular α1- and α2-adrenoceptors. It also antagonises the vasoconstrictor response to noradrenaline and adrenaline infusions.

Niacin (nicotinic acid) is an essential B complex Vitamin (B3), whose deficiency results in the clinical syndrome known as pellagra. Nicotinamide (niacinamide), the active ingredient, is the physiologically active form of niacin and is the chemical form of Vitamin B3 found in virtually all multivitamin products. Though nicotinic acid and nicotinamide are so closely related chemically, they differ somewhat in pharmacological properties.

Related product monographs

Document Type Information Source  
 CLARANTIN Hard capsule MPI, EU: SmPC Υπουργείο Υγείας (CY)
 OPILON Film-coated tablet MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 TRENTAL 400 Modified release tablet MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)